Li et al. found that MRPL52 overexpression in breast cancer is induced by hypoxia-inducible factor 1 in response to hypoxic exposure, demonstrating its role in inhibiting apoptosis and promoting migration and invasion of hypoxic breast cancer cells (Li et al. 2021). This evidence concerns the gene MRPL52 and breast cancer.